Editor's Choice Vested interests BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1922 (Published 08 April 2010) Cite this as: BMJ 2010;340:c1922 Article Related content Metrics Responses Peer review Related articles News Appeal court judges say scientific controversies must be settled by science not law Published: 01 April 2010; BMJ 340 doi:10.1136/bmj.c1895 Views & Reviews We should reform libel laws in light of Singh victory Published: 07 April 2010; BMJ 340 doi:10.1136/bmj.c1910 Research Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review Published: 19 March 2010; BMJ 340 doi:10.1136/bmj.c1344 Feature Rosiglitazone, marketing, and medical science Published: 07 April 2010; BMJ 340 doi:10.1136/bmj.c1848 News Doctors join protest over change to FDA rules on conflict of interest Published: 18 August 2011; BMJ 343 doi:10.1136/bmj.d5269 See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362
